Shuai Lü

4.1k total citations · 1 hit paper
144 papers, 2.9k citations indexed

About

Shuai Lü is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Shuai Lü has authored 144 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 22 papers in Computational Theory and Mathematics and 21 papers in Organic Chemistry. Recurrent topics in Shuai Lü's work include Computational Drug Discovery Methods (22 papers), Alzheimer's disease research and treatments (12 papers) and Acute Myeloid Leukemia Research (10 papers). Shuai Lü is often cited by papers focused on Computational Drug Discovery Methods (22 papers), Alzheimer's disease research and treatments (12 papers) and Acute Myeloid Leukemia Research (10 papers). Shuai Lü collaborates with scholars based in China, United States and United Kingdom. Shuai Lü's co-authors include Rui‐tian Liu, Yadong Chen, Xiaoge Liu, Soumalya Bhattacharyya, Koushik Acharyya, Peter J. Stang, Tao Lu, Xiaolin Yu, Jie Zhu and Haichun Liu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Shuai Lü

131 papers receiving 2.9k citations

Hit Papers

AGIEval: A Human-Centric Benchmark for Evaluating Foundat... 2024 2026 2025 2024 20 40 60

Peers

Shuai Lü
Siyu He China
Shuai Lü
Citations per year, relative to Shuai Lü Shuai Lü (= 1×) peers Siyu He

Countries citing papers authored by Shuai Lü

Since Specialization
Citations

This map shows the geographic impact of Shuai Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Lü more than expected).

Fields of papers citing papers by Shuai Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Lü. The network helps show where Shuai Lü may publish in the future.

Co-authorship network of co-authors of Shuai Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai Lü. A scholar is included among the top collaborators of Shuai Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai Lü. Shuai Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Tingting, Rui Yuan, Shuai Lü, et al.. (2025). Establishment of a clinically relevant beagle model for periprosthetic joint infection with 3D-printed prostheses and multimodal evaluation. Journal of Orthopaedic Translation. 53. 274–285.
2.
Lü, Shuai, et al.. (2025). Analysis on the Improvement of Formaldehyde Hazards in a Spray Painting Position in Automobile Manufacturing. E3S Web of Conferences. 615. 2011–2011.
3.
Liu, Ziqiang, Siyun Wang, Shuai Lü, et al.. (2025). Isolation and characterization of a novel K3-type capsule-targeting phage for the treatment of carbapenem-resistant Acinetobacter baumannii. Microbiology Spectrum. 13(12). e0109825–e0109825.
4.
Song, Juncai, et al.. (2025). Motor Signal Processing and Fault Diagnosis Based on an Analog Circuit Inspired by a Machine Learning Algorithm. IEEE Transactions on Instrumentation and Measurement. 74. 1–15.
5.
Cao, Yan, et al.. (2024). Ionic double-shell magnetic covalent organic framework for sharp and fast adsorption of critical metals. Separation and Purification Technology. 341. 126846–126846. 6 indexed citations
6.
Wang, Zhijie, Xun Lu, Fei Huang, et al.. (2024). Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations. European Journal of Medicinal Chemistry. 268. 116237–116237. 4 indexed citations
7.
Lü, Shuai, et al.. (2024). WMBAL: weighted minimum bounds for active learning. Applied Intelligence. 54(3). 2551–2563. 1 indexed citations
8.
Fang, Chao, Rui Zhong, Gang Yu, et al.. (2024). CDKN1A regulation on chondrogenic differentiation of human chondrocytes in osteoarthritis through single-cell and bulk sequencing analysis. Heliyon. 10(5). e27466–e27466. 4 indexed citations
9.
Wang, Zhijie, Donglin Wu, Xiaofei Zhao, et al.. (2023). Rational discovery of dual FLT3/HDAC inhibitors as a potential AML therapy. European Journal of Medicinal Chemistry. 260. 115759–115759. 12 indexed citations
10.
Zhi, Yanle, Hongmei Li, Qiaomei Jin, et al.. (2023). Rational design of 4-((6-phenoxypyrimidin-4-yl)amino)-N-(4-(piperazin-1-yl)phenyl)-1H-pyrazole-3-carboxamide (LT-540-717) as orally bioavailable FLT3 inhibitor. European Journal of Medicinal Chemistry. 256. 115448–115448. 5 indexed citations
11.
Zhao, Xiaofei, Donglin Wu, Fei Huang, et al.. (2023). Hydrophobic tag-based protein degradation: Development, opportunity and challenge. European Journal of Medicinal Chemistry. 260. 115741–115741. 33 indexed citations
12.
Wang, Yu, Shuai Lü, Xu‐Qing Wang, et al.. (2021). Synthesis, structure elucidation and functionalization of sulfonamide [2]catenanes. Organic Chemistry Frontiers. 8(18). 4994–5001. 13 indexed citations
13.
Cheng, Jie, et al.. (2021). FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance. Journal of Medicinal Chemistry. 64(6). 2878–2900. 67 indexed citations
14.
Zhang, Yanmin, Yi Hua, Yuchen Wang, et al.. (2019). Investigation of Machine Intelligence in Compound Cell Activity Classification. Molecular Pharmaceutics. 16(11). 4472–4484. 7 indexed citations
15.
Ran, Ting, Wenjuan Li, Bing‐ling Peng, et al.. (2019). Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1. Journal of Chemical Information and Modeling. 59(1). 522–534. 13 indexed citations
16.
Wang, Zhijie, Hongmei Li, Liang Zhang, et al.. (2019). Combining structure- and property-based optimization to identify selective FLT3-ITD inhibitors with good antitumor efficacy in AML cell inoculated mouse xenograft model. European Journal of Medicinal Chemistry. 176. 248–267. 13 indexed citations
17.
Meng, Lijuan, Yan Zhou, Jing Han, et al.. (2019). A cis‐eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma. Cancer Medicine. 8(14). 6476–6484. 13 indexed citations
18.
Zhi, Yanle, Haoliang Yuan, Zhijie Wang, et al.. (2018). Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation. European Journal of Medicinal Chemistry. 163. 195–206. 18 indexed citations
20.
Ran, Ting, Zhimin Zhang, Kejun Liu, et al.. (2015). Insight into the key interactions of bromodomain inhibitors based on molecular docking, interaction fingerprinting, molecular dynamics and binding free energy calculation. Molecular BioSystems. 11(5). 1295–1304. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026